These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 10708066)

  • 1. Polymerase chain reaction monitoring of HIV-1 infection: should the CCR5 genotype be considered?
    Barlow KL; Clewley JP
    J Acquir Immune Defic Syndr; 2000 Jan; 23(1):102-3. PubMed ID: 10708066
    [No Abstract]   [Full Text] [Related]  

  • 2. Frequency of polymorphisms of genes coding for HIV-1 co-receptors CCR5 and CCR2 in a Brazilian population.
    Munerato P; Azevedo ML; Sucupira MC; Pardini R; Pinto GH; Catroxo M; Souza IE; Diaz RS
    Braz J Infect Dis; 2003 Aug; 7(4):236-40. PubMed ID: 14533983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between CCR5 genotype and the clinical course of HIV-1 infection.
    de Roda Husman AM; Koot M; Cornelissen M; Keet IP; Brouwer M; Broersen SM; Bakker M; Roos MT; Prins M; de Wolf F; Coutinho RA; Miedema F; Goudsmit J; Schuitemaker H
    Ann Intern Med; 1997 Nov; 127(10):882-90. PubMed ID: 9382366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of CCR5-delta32 heterozygosity on the risk of perinatal HIV-1 infection: a meta-analysis.
    Contopoulos-Ioannidis DG; O'Brien TR; Goedert JJ; Rosenberg PS; Ioannidis JP
    J Acquir Immune Defic Syndr; 2003 Jan; 32(1):70-6. PubMed ID: 12514416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a third CCR5 amplicon from CCR5-delta32-heterozygous HIV-1-infected individuals.
    Aikhionbare FO; Newman C; Womack C; Roth WW; Stringer HG; Bond VC
    AIDS; 1999 Aug; 13(12):1585-6. PubMed ID: 10465086
    [No Abstract]   [Full Text] [Related]  

  • 6. CCR5 promoter polymorphisms, CCR5 59029A and CCR5 59353C, are under represented in HIV-1-infected long-term non-progressors. The Australian Long-Term Non-Progressor Study Group.
    Clegg AO; Ashton LJ; Biti RA; Badhwar P; Williamson P; Kaldor JM; Stewart GJ
    AIDS; 2000 Jan; 14(2):103-8. PubMed ID: 10708279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCR5 genotypes and progression to HIV disease in perinatally infected children.
    de Angelis DS; Freire WS; Pannuti CS; Succi RC; Machado DM
    Braz J Infect Dis; 2007 Apr; 11(2):196-8. PubMed ID: 17625759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of CCR5-{delta}32, CCR2-64I, and SDF1-3'A in Guangxi Zhuang population.
    Qijian Su ; Zhidan Mai ; Ning Zang ; Shuzhi Wu ; Xin Xiao ; Hao Liang
    J Int Assoc Physicians AIDS Care (Chic); 2010; 9(3):145-9. PubMed ID: 20530467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restriction of HIV type 1 infection in macrophages heterozygous for a deletion in the CC-chemokine receptor 5 gene.
    Ometto L; Zanchetta M; Cabrelle A; Esposito G; Mainardi M; Chieco-Bianchi L; De Rossi A
    AIDS Res Hum Retroviruses; 1999 Nov; 15(16):1441-52. PubMed ID: 10555107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of mother-to-infant transmission of HIV-1 is not reduced in CCR5/delta32ccr5 heterozygotes.
    Edelstein RE; Arcuino LA; Hughes JP; Melvin AJ; Mohan KM; King PD; McLellan CL; Murante BL; Kassman BP; Frenkel LM
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Dec; 16(4):243-6. PubMed ID: 9402070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1-infected long-term slow progressors heterozygous for delta32-CCR5 show significantly lower plasma viral load than wild-type slow progressors.
    Walli R; Reinhart B; Luckow B; Lederer E; Loch O; Malo A; Wank R; Schlöndorff D; Goebel FD
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Jul; 18(3):229-33. PubMed ID: 9665499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cysteine-cysteine chemokine receptor 5 (CCR5) profile of HIV-infected subjects attending University of Calabar Teaching Hospital, Calabar, Southern Nigeria.
    Ekere EF; Useh MF; Okoroiwu HU; Mirabeau TY
    BMC Infect Dis; 2020 Jan; 20(1):5. PubMed ID: 31900106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCR5 promoter polymorphisms in a Kenyan perinatal human immunodeficiency virus type 1 cohort: association with increased 2-year maternal mortality.
    John GC; Bird T; Overbaugh J; Nduati R; Mbori-Ngacha D; Rostron T; Dong T; Kostrikis L; Richardson B; Rowland-Jones SL
    J Infect Dis; 2001 Jul; 184(1):89-92. PubMed ID: 11398114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of the CCR5 delta32 allele in Italian HIV type 1-infected and normal individuals.
    Battiloro E; Andreoni M; Parisi SG; Mura MS; Sotgiu G; Aceti A; Cossu G; Concia E; Verna R; D'Ambrosio E
    AIDS Res Hum Retroviruses; 2000 Jan; 16(2):181-2. PubMed ID: 10659057
    [No Abstract]   [Full Text] [Related]  

  • 15. Lack of protection from HIV infection by the mutant HIV coreceptor CCR5 in intravenously HIV infected hemophilia patients.
    Malo A; Rommel F; Bogner J; Gruber R; Schramm W; Goebel FD; Riethmüller G; Wank R
    Immunobiology; 1998 Feb; 198(4):485-8. PubMed ID: 9562872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCR5 genotype and plasma beta-chemokine concentration of Brazilian HIV-infected individuals.
    Mikawa AY; Tagliavini SA; Costa PI
    Braz J Med Biol Res; 2002 Nov; 35(11):1333-7. PubMed ID: 12426633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased susceptibility of peripheral blood mononuclear cells from individuals heterozygous for a mutant CCR5 allele to HIV infection.
    Kim A; Pettoello-Mantovani M; Goldstein H
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Oct; 19(2):145-9. PubMed ID: 9768623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms in CCR5Δ32 and Risk of HIV-1 Infection in the Southeast of Caspian Sea, Iran.
    Heydarifard Z; Tabarraei A; Moradi A
    Dis Markers; 2017; 2017():4190107. PubMed ID: 29209099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCR5 chemokine receptor variant in HIV-1 mother-to-child transmission and disease progression in children. French Pediatric HIV Infection Study Group.
    Misrahi M; Teglas JP; N'Go N; Burgard M; Mayaux MJ; Rouzioux C; Delfraissy JF; Blanche S
    JAMA; 1998 Jan; 279(4):277-80. PubMed ID: 9450710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One copy of mutation may help resistance: study.
    AIDS Alert; 2002 Feb; 17(2):23-4, 14. PubMed ID: 11862745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.